Investors/SV Health Investors

2 London Mempool companies backed by SV Health Investors

Rank =208 of 430 on the investor leaderboard. A source says it led a round in 1 of them.

See them on the mapCounts only deals named in a source we fetched

Inner London. Coloured dots are the portfolio, grey dots the rest of the map.

Portfolio by sector

Health22 Health companies

Portfolio on the map (2)

Alchemab Therapeutics
Develops antibody therapeutics found in the immune systems of disease-resilient people, using AI on antibody repertoires.
Health · Antibody Discovery · Fastest growing
source: european-biotechnology.com
Quell Therapeutics
Develops engineered CAR-Treg cell therapies for autoimmune disease and organ transplant rejection.
Health · Cell Therapy · Up and comingLed a round
source: quell-tx.com

We list SV Health Investors on a company only when a page we fetched names it as an investor. Its real London portfolio is likely bigger. Know a deal we missed? Suggest a fix with a source. How we count